One dose can reduce the risk of hospitalization by up to 81 percent after 4 weeks.
REPUBLIKA.CO.ID, LONDON – One injection of the coronavirus is claimed to reduce the risk of hospital admission by more than 90 percent according to a recent study. The Oxford-AstraZeneca vaccine has been shown to be more effective in reducing hospitalizations.
The report, which is the result of a large-scale trial, will be released this month. It was revealed that the Oxford-AstraZeneca vaccine is effective in preventing serious diseases that can be caused by the corona virus. The results showed that even those over the age of 70 were less likely to need hospital care after receiving only one injection.
Researchers created the latest efficacy figures by comparing hospital admissions rates for the coronavirus across the UK for people who had received the first dose in the country’s vaccine launch with those who couldn’t. The report drew the same conclusions as a study on the hospital admission rate for the coronavirus in Scotland released last week.
Researchers at the University of Edinburgh found four weeks after the injection, the Pfizer-BioNTech and Oxford-AstraZeneca injections reduced the risk of hospital admission by 85 percent and 94 percent, respectively. For people over 80 years of age, one injection can reduce the risk inpatient up to 81 percent after four weeks, according to the combined results of the British and Scottish studies.
“This provides evidence of the high effectiveness of the Oxford-AstraZeneca and BioNTech-Pfizer vaccines in preventing hospitalization of people over 80 years of age after a single dose, supporting our belief in using this vaccine in adults of all ages,” said the head of the project. University of Oxford vaccine, Prof. Sarah Gilbert, quoted from Arab News on Tuesday (2/3).
It is known that the UK vaccine program has given initial injections to about 20 million people. The policy is said to be able to result in a rapid reduction in the number of hospital patients and death from the virus in all age groups.
– .
